HCPLive previewed the upcoming American Thoracic Society (ATS) International Conference, including an upcoming expert interview with Gerard J. Criner, MD, FACP, FACCP, Director of the Temple Lung Center, on two of his ATS posters and an ATS mini-symposium. The mini-symposium is on pegtarazimod, a dual-acting, anti-inflammatory peptide. The posters cover tezepelumab, a human monoclonal antibody, and pooled results from the METREX, METREO and MATINEE trials on mepolizumab, a humanized monoclonal antibody specifically targeting interleukin-5.
800-TEMPLE-MED
Request Appointment
SEARCH TEMPLE HEALTH